Hans Modig
Impact in
-
- Gastric Cancer Management and Outcomes
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Biochemistry top 5%
- Sulfur Compounds in Biology
Papers in
-
- Prostate Cancer Diagnosis and Treatment 5
- Prostate Cancer Treatment and Research 2
-
- Sulfur Compounds in Biology 6
- Amino Acid Enzymes and Metabolism 5
- Co-authors
- Láśzló Révész (8 shared papers)Jan‐Erik Damber (6 shared papers)Radiša Tomić (5 shared papers)Torvald Granfors (4 shared papers)Hanne Sand Hansen (3 shared papers)Johan Tausjø (3 shared papers)Bengt Rosengren (3 shared papers)Reidulv Hatlevoll (2 shared papers)
In The Last Decade
Hans Modig
25 papers receiving 1.2k citations
Hans Modig's Hit Papers
Peers
Comparison fields: 5 of 84
- Pulmonary and Respiratory Medicine 584
- Biochemistry 140
- Surgery 567
- Otorhinolaryngology 41
- Cancer Research 118
Countries citing papers authored by Hans Modig
This map shows the geographic impact of Hans Modig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Modig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Modig more than expected).
Fields of papers citing papers by Hans Modig
This network shows the impact of papers produced by Hans Modig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Modig. The network helps show where Hans Modig may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Modig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer Hit paper breakdown → | 1992 | 474 |
| 2 | 1998 | 167 | |
| 3 | 1997 | 80 | |
| 4 | 1968 | 79 | |
| 5 | 1963 | 75 | |
| 6 | 1965 | 68 | |
| 7 | 2006 | 61 | |
| 8 | 2001 | 54 | |
| 9 | 1997 | 40 | |
| 10 | 1992 | 35 | |
| 11 | 1972 | 34 | |
| 12 | 1968 | 32 | |
| 13 | 1993 | 27 | |
| 14 | 1974 | 25 | |
| 15 | 1990 | 16 | |
| 16 | 1996 | 15 | |
| 17 | 1977 | 14 | |
| 18 | 1997 | 9 | |
| 19 | 1990 | 9 | |
| 20 | 1973 | 9 |
About Hans Modig
Hans Modig is a scholar working on Pulmonary and Respiratory Medicine, Biochemistry, Molecular Biology, Oncology and Surgery, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sulfur Compounds in Biology (6 papers), Amino Acid Enzymes and Metabolism (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (3 papers), Estrogen and related hormone effects (3 papers), Advanced Radiotherapy Techniques (2 papers), Esophageal Cancer Research and Treatment (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (584 citations), Biochemistry (140 citations), Surgery (567 citations), Otorhinolaryngology (41 citations) and Cancer Research (118 citations). Hans Modig has collaborated with scholars based in Sweden, Denmark and Norway. Frequent co-authors include Láśzló Révész, Jan‐Erik Damber, Radiša Tomić, Torvald Granfors, Hanne Sand Hansen, Johan Tausjø, Bengt Rosengren, Reidulv Hatlevoll, M Mäntylä and Steinar Hagen. Their work appears in journals such as The Journal of Urology, Biochemical Pharmacology, International Journal of Radiation Oncology*Biology*Physics, Nature and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.